Cargando…

Synergistic Inhibition of Survival, Proliferation, and Migration of U87 Cells with a Combination of LY341495 and Iressa

Glioblastomas exploit various molecular pathways to promote glutamate- dependent growth by activating the AMPA (2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl) propanoic acid) receptor, the group II metabotropic glutamate receptor, mGluR, and the epidermal growth factor receptor, EGFR. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yelskaya, Zarina, Carrillo, Vangie, Dubisz, Ewa, Gulzar, Hira, Morgan, Devon, Mahajan, Shahana S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664620/ https://www.ncbi.nlm.nih.gov/pubmed/23724064 http://dx.doi.org/10.1371/journal.pone.0064588

Ejemplares similares

AMPA receptor-mTORC1 signaling activation is required for neuroplastic effects of LY341495 in rat hippocampal neurons
por: Seo, Mi kyoung, et al.
Publicado: (2020)

Effects of Chronic LY341495 on Hippocampal mTORC1 Signaling in Mice with Chronic Unpredictable Stress-Induced Depression
por: Seo, Mi Kyoung, et al.
Publicado: (2022)

Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats
por: Podkowa, Karolina, et al.
Publicado: (2016)

Osteosarcoma cell proliferation and survival requires mGluR5 receptor activity and is blocked by Riluzole
por: Liao, Sally, et al.
Publicado: (2017)

Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma
por: Gemmill, R M, et al.
Publicado: (2005)

Effects of post-training administration of LY341495, as an mGluR2/3 antagonist on spatial memory deficit in rats fed with high-fat diet
por: Moridi, Heresh, et al.
Publicado: (2020)

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist
por: McCullock, Tyler W., et al.
Publicado: (2019)

The Antidepressant-like Activity and Cognitive Enhancing Effects of the Combined Administration of (R)-Ketamine and LY341495 in the CUMS Model of Depression in Mice Are Related to the Modulation of Excitatory Synaptic Transmission and LTP in the PFC
por: Pałucha-Poniewiera, Agnieszka, et al.
Publicado: (2023)

Combined Administration of (R)-Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Induces Rapid and Sustained Effects in the CUMS Model of Depression via a TrkB/BDNF-Dependent Mechanism
por: Rafało-Ulińska, Anna, et al.
Publicado: (2022)

Laminin-5 offsets the efficacy of gefitinib (‘Iressa’) in hepatocellular carcinoma cells
por: Giannelli, G, et al.
Publicado: (2004)

Thymoquinone synergistically potentiates temozolomide cytotoxicity through the inhibition of autophagy in U87MG cell line
por: Pazhouhi, Mona, et al.
Publicado: (2016)

Temozolomide and tranilast synergistic antiproliferative effect on human glioblastoma multiforme cell line (U87MG)
por: Khazaei, Mozafar, et al.
Publicado: (2019)

Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors
por: Blackledge, G, et al.
Publicado: (2004)

TRAIL and Paclitaxel Synergize to Kill U87 Cells and U87-Derived Stem-Like Cells in Vitro
por: Qiu, Bo, et al.
Publicado: (2012)

Synergistic Apoptotic Effects of Tocotrienol Isomers and Acalypha wilkesiana on A549 and U87MG Cancer Cells
por: Abubakar, Ibrahim Babangida, et al.
Publicado: (2018)

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
por: Sewell, J M, et al.
Publicado: (2002)

Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
por: Kirby, A M, et al.
Publicado: (2006)

Molecular mechanisms underlying the interaction between ZD1839 (‘Iressa’) and cisplatin/5-fluorouracil
por: Magné, N, et al.
Publicado: (2003)

The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours
por: Knight, Louise A, et al.
Publicado: (2004)

Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme
por: Kutwin, Marta, et al.
Publicado: (2016)

Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer Cells
por: Wempe, Stacy L., et al.
Publicado: (2013)

Additive interaction of gefitinib (‘Iressa’, ZD1839) and ionising radiation in human tumour cells in vitro
por: Giocanti, N, et al.
Publicado: (2004)

Exosome Proteome of U-87MG Glioblastoma Cells
por: Chun, Sohyun, et al.
Publicado: (2016)

N-(2-hydroxyphenyl)acetamide (NA-2) and Temozolomide synergistically induce apoptosis in human glioblastoma cell line U87
por: Hanif, Farina, et al.
Publicado: (2014)

Characterization and function of human Ly-6/uPAR molecules
por: Kong, Hyun Kyung, et al.
Publicado: (2012)

Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells
por: Metz, Claudia, et al.
Publicado: (2016)

Quantifying Deformation and Migration Properties of U87 Glioma Cells Using Dielectrophoretic Forces
por: Elitas, Meltem, et al.
Publicado: (2022)

Sequence-dependent effects of ZD1839 (‘Iressa’) in combination with cytotoxic treatment in human head and neck cancer
por: Magné, N, et al.
Publicado: (2002)

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation
por: Noro, Rintaro, et al.
Publicado: (2006)

Proton beam irradiation stimulates migration and invasion of human U87 malignant glioma cells
por: Zaboronok, Alexander, et al.
Publicado: (2014)

Orientational Preferences of GPI-Anchored Ly6/uPAR Proteins
por: Zaigraev, Maxim M., et al.
Publicado: (2022)

Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA)
por: Kimura, H, et al.
Publicado: (2007)

Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro
por: Bernhart, Eva, et al.
Publicado: (2013)

Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration
por: LI, YANG, et al.
Publicado: (2016)

Rutaecarpine Inhibits U87 Glioblastoma Cell Migration by Activating the Aryl Hydrocarbon Receptor Signaling Pathway
por: Liu, Yiyun, et al.
Publicado: (2021)

Synergistic regulation mechanism of iperoxo and LY2119620 for muscarinic acetylcholine M2 receptor
por: Li, Quan, et al.
Publicado: (2018)

ID1 regulates U87 human cell proliferation and invasion
por: GUO, PIN, et al.
Publicado: (2013)

Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells
por: Mesti, Tanja, et al.
Publicado: (2014)

Lessons from the ‘Iressa’ Expanded Access Programme: gefitinib in special non-small-cell lung cancer patient populations
por: Stahel, R, et al.
Publicado: (2003)

Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells
por: Li, Weiguo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8jm9t9ru46l44qqouckvo9agk